"With the first pre-validated SaaS-based CRM application, Veeva Systems is setting the standard for the way things will evolve in the pharmaceutical industry."
- Patrick P. Den Boer, CEO of Q Pharma
There are many significant advantages of the SaaS model. Most popularly discussed are the lack of up front costs, no hardware or system software to install and maintain, free upgrades, and super reliability. For the pharmaceutical industry, there is another important advantage that Veeva Systems has exposed – the ability to pre-validate the system for PDMA and CFR Part 11 compliance.
Veeva Systems hired industry expert, CSSC Incorporated, to fully validate our call reporting and sampling system, including VBioPharma Mobile. With the completion and full documentation of all IQ and OQ tests, our customers will save 80% of their system validation costs while eliminating the project time normally required for this part of the implementation. In addition, all future versions of VBioPharma will be validated by CSSC, ensuring ongoing compliance for all Veeva customers.
With the pre-validation of VBioPharma, Veeva customers will enjoy:
- 80% cost savings on system validation
- Faster implementations
- Lower risk
- Higher product quality
Visit the Veeva Demo Center to see the product in action or contact us today.
> More
> Contact Us